SCI index-based risk stratification for anti-inflammatory therapy in acute type a aortic dissection
Year: 2026
Type: article
Study design: Observational Study
Abstract: This study aimed to evaluate the utility of the systemic coagulation-inflammation index (SCI) in perioperative risk stratification for anti-inflammatory therapy in patients with acute type A aortic dissection (ATAAD). A retrospective cohort of 339 consecutive ATAAD patients was analyzed. Patients were stratified into two groups based on the threshold of SCI index: high-risk group (SCI < 40, n = 233), low-risk group (SCI ≥ 40, n = 106). Multivariable linear regression was performed within the high-risk group to assess the independent association between ulinastatin use and postoperative cardiovascular function, adjusting for potential confounders. An interaction analysis was conducted to formally test whether the treatment effect varied by risk level. An exploratory mediation analysis was also conducted. The high-risk group exhibited more severe inflammation and organ dysfunction, with significantly higher rates of systemic inflammatory response syndrome (SIRS) before surgery ( P = 0.012), cumulative incidence of SIRS within 7 days after surgery ( P = 0.015), and higher mean daily total modified Sequential Organ Failure Assessment (SOFA) score (high-risk group: 6.5 [IQR 4.1–9.0]; low-risk group: 3.7 [IQR 2.7–6.0]; P < 0.001). While ulinastatin was associated with lower rates of SIRS in both groups ( P < 0.001), high-risk patients showed more pronounced and earlier differences in inflammatory and organ-dysfunction, including a lower mean daily modified SOFA score on postoperative day 1 ( P = 0.038) and a lower mean daily cardiovascular score ( P = 0.008), as well as a lower rate of SIRS immediately after surgery ( P = 0.005). Multivariable analysis showed that ulinastatin use was independently associated with a lower cardiovascular SOFA score in the high-risk group ( P < 0.001), and a significant interaction was observed between additional ulinastatin use and risk level ( P for interaction = 0.029). The SCI index is a moderate predictor of adverse outcomes in ATAAD patients and may serve as a potential risk stratification tool. High-risk patients showed a more pronounced inverse association between ulinastatin use and postoperative cardiovascular dysfunction.
Authors: Qing-yuan Wang, Hong Liu, Yong-feng Shao
Institution: Jiangsu Province Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,890
OpenAlex ID: W7235943044
